Buscar
Mostrando ítems 1-10 de 3358
Farmacología
(Servicio Nacional de Aprendizaje (SENA)División de Comercio y Servicios, 2014)
Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
(Taylor and Francis, 2016)
From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Gram-positive microorganisms, this ...
Current pharmacological treatments for SARS-COV-2: A narrative review
Current pharmacological treatments for SARS-COV-2: A narrative review
Entinostat (SNDX-275) for the treatment of non-small cell lung cancer
(Taylor and Francis, 2015)
INTRODUCTION: Epigenetic aberrations play an important role in lung carcinogenesis. Chromatin deacetylation is a fundamental mechanism of gene silencing. Histone deacetylase (HDAC) inhibitors are an emerging class of ...
Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis
(Oxford University Press, 2016)
Background. The efficacy of current antiparasitic treatment for cerebral Taenia solium cysticercosis with either albendazole (ABZ) or praziquantel (PZQ) is suboptimal. A recent study demonstrated that combining these 2 ...
Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru
(American Society of Tropical Medicine and Hygiene, 2014)
We evaluated the efficacy of three primaquine (PQ) regimes to prevent relapses with Plasmodium vivax through an open-label randomized trial in Loreto, Peru. Vivax monoinfections were treated with chloroquine for 3 days and ...
SARS-CoV-2 pharmacologic therapies and their safety/ effectiveness according to level of evidence
Introduction: There is a pressing need for COVID-19 transmission control and effective treatments. We
aim to evaluate the safety and effectiveness of SARS-CoV-2 pharmacologic therapies as of August 2,
2020 according to ...